Wolverine Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Wolverine Asset Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-100,100	Closed	-$119K	–	2649
2022 Q3	$119K	Hold	100,100	–	–	﹤0.01%	1383
2022 Q2	$180K	Hold	100,100	–	–	﹤0.01%	1228
2022 Q1	$202K	Sell	100,100 -5,600	-5%	-$11K	﹤0.01%	1165
2021 Q4	$286K	Buy	105,700 +100	+0.1%	+$370	﹤0.01%	1149
2021 Q3	$470K	Buy	105,600 +100,000	+1,786%	+$482K	﹤0.01%	975
2021 Q2	$32K	Sell	5,600 -1,000	-15%	-$5.86K	﹤0.01%	1791
2021 Q1	$46K	Sell	6,600 -486,600	-99%	-$3.26M	﹤0.01%	1651
2020 Q4	$2.37M	Buy	493,200 +6,100	+1%	+$30.9K	0.02%	407
2020 Q3	$2.84M	Hold	487,100	–	–	0.03%	332
2020 Q2	$3.29M	Sell	487,100 -126,200	-21%	-$956K	0.03%	299
2020 Q1	$3.9M	Sell	613,300 -66,300	-10%	-$532K	0.06%	246
2019 Q4	$7.08M	Buy	679,600 +263,300	+63%	+$1.91M	0.08%	194
2019 Q3	$1.64M	Buy	416,300 +392,300	+1,635%	+$3.17M	0.02%	474
2019 Q2	$356K	Buy	24,000 +9,800	+69%	+$177K	﹤0.01%	921
2019 Q1	$352K	Sell	14,200 -1,600	-10%	-$40.1K	﹤0.01%	940
2018 Q4	$283K	Buy	15,800 +7,600	+93%	+$155K	﹤0.01%	1171
2018 Q3	$240K	Hold	8,200	–	–	﹤0.01%	1166
2018 Q2	$372K	Hold	8,200	–	–	﹤0.01%	1001
2018 Q1	$432K	Sell	8,200 -15,300	-65%	-$893K	0.01%	1011
2017 Q4	$1.6M	Hold	23,500	–	–	0.02%	588
2017 Q3	$1.94M	Sell	23,500 -12,700	-35%	-$1.01M	0.02%	496
2017 Q2	$3.39M	Sell	36,200 -17,300	-32%	-$1.06M	0.04%	312
2017 Q1	$3.41M	Buy	53,500 +9,500	+22%	+$578K	0.05%	288
2016 Q4	$1.95M	Buy	44,000 +35,300	+406%	+$1.24M	0.03%	404
2016 Q3	$313K	Sell	8,700 -17,500	-67%	-$375K	﹤0.01%	784
2016 Q2	$359K	Buy	26,200 +26,057	+18,222%	+$381K	0.01%	774
2016 Q1	$992K	Sell	143 -36	-20%	-$762	0.03%	396
2015 Q4	$888K	Hold	179	–	–	0.02%	517
2015 Q3	$501K	Buy	179 +74	+70%	+$6.4K	0.01%	676
2015 Q2	$6K	Sell	105 -100	-49%	-$8.56K	﹤0.01%	1664
2015 Q1	$18K	Hold	205	–	–	﹤0.01%	1469
2014 Q4	$41K	Buy	+205	New	+$10.8K	﹤0.01%	1448